About Us
SpineThera is a clinical stage pharmaceutical company working to improve the lives of patients by creating injectable drugs utilizing its micro-suspension platform technology. SpineThera’s micro-suspension provides months long sustained-release of the active pharmaceutical ingredient with superior injectability at ultra-high concentrations.
The company’s lead investigational drug product, SX600, is a novel formulation of dexamethasone being developed for sciatica. SX600 was recently studied in a successful
Phase 2 clinical trial.